IL135799A0 - Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration - Google Patents

Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration

Info

Publication number
IL135799A0
IL135799A0 IL13579998A IL13579998A IL135799A0 IL 135799 A0 IL135799 A0 IL 135799A0 IL 13579998 A IL13579998 A IL 13579998A IL 13579998 A IL13579998 A IL 13579998A IL 135799 A0 IL135799 A0 IL 135799A0
Authority
IL
Israel
Prior art keywords
methods
nervous system
central nervous
neuronal regeneration
mammalian central
Prior art date
Application number
IL13579998A
Other languages
English (en)
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2219683 external-priority patent/CA2219683A1/fr
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of IL135799A0 publication Critical patent/IL135799A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13579998A 1997-10-28 1998-10-28 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration IL135799A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2219683 CA2219683A1 (fr) 1997-10-28 1997-10-28 Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes
CA2251410 1998-10-16
PCT/CA1998/000997 WO1999021581A1 (fr) 1997-10-28 1998-10-28 Compositions et procedes immunologiques utilises pour modifier provisoirement la myeline du systeme nerveux central des mammiferes afin de stimuler la regeneration neuronale

Publications (1)

Publication Number Publication Date
IL135799A0 true IL135799A0 (en) 2001-05-20

Family

ID=25679779

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13579998A IL135799A0 (en) 1997-10-28 1998-10-28 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
IL135799A IL135799A (en) 1997-10-28 2000-04-24 Immunological compositions to transiently alter mammalian central nervous system myelin to promote neuronal regeneration

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL135799A IL135799A (en) 1997-10-28 2000-04-24 Immunological compositions to transiently alter mammalian central nervous system myelin to promote neuronal regeneration

Country Status (11)

Country Link
US (2) US6548061B1 (fr)
EP (1) EP1047449B1 (fr)
JP (1) JP2001521008A (fr)
AT (1) ATE249241T1 (fr)
AU (1) AU748143B2 (fr)
DE (1) DE69818106T2 (fr)
DK (1) DK1047449T3 (fr)
ES (1) ES2210829T3 (fr)
IL (2) IL135799A0 (fr)
PT (1) PT1047449E (fr)
WO (1) WO1999021581A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542299A (ja) * 1999-04-28 2002-12-10 ユニバーシティ・オブ・ブリティッシュ・コロンビア ミエリン特異性抗体および補体タンパク質を含むニューロン再生用組成物
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
TWI323265B (en) * 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
NZ576195A (en) 2006-10-10 2012-04-27 Az Univ Amsterdam Complement inhibition for improved nerve regeneration
SG190997A1 (en) * 2010-12-09 2013-07-31 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
UY35468A (es) 2013-03-16 2014-10-31 Novartis Ag Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
US10058471B2 (en) * 2014-02-21 2018-08-28 William M. Vaughan System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries
DK3129470T3 (da) 2014-04-07 2021-07-05 Novartis Ag Behandling af cancer ved anvendelse af anti-CD19-kimær antigenreceptor
HUE059218T2 (hu) 2015-04-08 2022-11-28 Novartis Ag CD20-terápiák, CD22-terápiák és kombinációs terápiák CD19 kiméra antigénreceptort (CAR-t) expresszáló sejttel
TW202340473A (zh) 2016-10-07 2023-10-16 瑞士商諾華公司 利用嵌合抗原受體之癌症治療

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6174490A (en) * 1989-08-04 1991-03-11 Board Of Regents, The University Of Texas System Methods and compositions; purified preparation of neural progenitor regulatory factor
US6020140A (en) * 1991-08-09 2000-02-01 Washington University Autoantibodies and their targets in the diagnosis of peripheral neuropathies
ATE187889T1 (de) * 1992-06-12 2000-01-15 Cephalon Inc Vorbeugung und behandlung der peripheren neuropathie
US5714385A (en) * 1995-05-10 1998-02-03 Genentech, Inc. Media for culturing schwann cells
US6228598B1 (en) * 1998-10-02 2001-05-08 Washington University Antibodies to heparan sulfate glycosaminoglycans in the diagnosis of polyneuropathies

Also Published As

Publication number Publication date
AU9617998A (en) 1999-05-17
JP2001521008A (ja) 2001-11-06
PT1047449E (pt) 2004-04-30
US6969516B1 (en) 2005-11-29
AU748143B2 (en) 2002-05-30
DK1047449T3 (da) 2004-01-26
EP1047449B1 (fr) 2003-09-10
ATE249241T1 (de) 2003-09-15
US6548061B1 (en) 2003-04-15
EP1047449A1 (fr) 2000-11-02
ES2210829T3 (es) 2004-07-01
DE69818106D1 (de) 2003-10-16
IL135799A (en) 2011-01-31
DE69818106T2 (de) 2004-06-17
WO1999021581A1 (fr) 1999-05-06

Similar Documents

Publication Publication Date Title
IL135799A0 (en) Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
Narayanan et al. Biosynthesis and regulation of type V collagen in diploid human fibroblasts.
DK1194167T3 (da) Immunoterapi af autoimmune sygdomme under anvendelse af B-cellespecifikke antistoffer
NL300372I1 (nl) Hybride immunoglobulinen voor gebruik bij therapeutische werkwijzen
ATE151113T1 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
MX7235E (es) Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune
DE69119278D1 (de) Monoklonaler Antikörper, der mit einer neuen HLA-Determinante auf MHC-Klasse-I-Moleküle reagiert, und Verfahren zur Aktivierung von Lymphozyten
ATE47155T1 (de) Monoklonaler antikoerper.
PT743856E (pt) Heteropolimeros a base de antigenes e metodo para o tratamento de doencas auto-imunes utilizando esses heteropolimeros
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
ES8605569A1 (es) Un procedimiento para preparar un fueloleo pre-atomizado combustible.
ATE248605T1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
DK121788A (da) Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse
BR9810409A (pt) Métodos e composições para a modulação de responsividade a corticosteróides
ATE112687T1 (de) Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
FI891528A0 (fi) Antikroppheterokonjugat foer anvaendning vid reglering av lymfocytaktivitet.
AU4626389A (en) Use of minoxidil for wound healing
CA2253078A1 (fr) Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones
DE69432472D1 (de) Verfahren zur hemmung der phagozytose
GB2214295B (en) "hapten determination method, use and components"
Dose et al. EFFECT OF UV‐IRRADIATION ON SEDIMENTATION BEHAVIOR OF VARIOUS PROTEINS
Ikuta et al. Purification of C-reactive protein
Flamini et al. Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis

Legal Events

Date Code Title Description
FF Patent granted